{
  "meta": {
    "title": "Paraneoplastic_Syndromes_-_Part_1",
    "url": "https://brainandscalpel.vercel.app/paraneoplastic-syndromes-part-1-274f2cab.html",
    "scrapedAt": "2025-11-29T18:25:01.386Z"
  },
  "questions": [
    {
      "id": 19833,
      "choices": [
        {
          "id": 79293,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP) </span></span></span></p>"
        },
        {
          "id": 79294,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC) </span></span></span></p>"
        },
        {
          "id": 79295,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Osteolytic bone metastases </span></span></span></p>"
        },
        {
          "id": 79296,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">All of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old woman with a history of squamous cell lung cancer presents with fatigue, constipation, and confusion. Her laboratory tests reveal a serum calcium level of 13 mg/dL. Which of the following is the MOST Common mechanism underlying her hypercalcemia?</span></span></p>",
      "unique_key": "Q8353660",
      "question_audio": null,
      "question_video": null,
      "map_id": 19744,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Increased bone resorption mediated by parathyroid hormone-related protein (PTHrP)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Squamous cell lung cancer&nbsp;</span></strong><span style=\"font-size:12.0pt\">is well-known for its ability to produce <strong>PTHrP</strong>. This protein mimics the action of parathyroid hormone, leading to increased bone resorption and calcium release into the bloodstream.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">While <strong>osteolytic bone metastases</strong> and <strong>ectopic production of 1,25 DHCC</strong> can also contribute to hypercalcemia in some cases of squamous cell lung cancer, they are <strong>less common</strong> than PTHrP-mediated bone resorption.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ectopic production of 1,25-dihydroxyvitamin D (1,25 DHCC):</span></strong><span style=\"font-size:12.0pt\"> This mechanism is more commonly seen in lymphomas and some other solid tumors, not as frequently in squamous cell lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Osteolytic bone metastases:</span></strong><span style=\"font-size:12.0pt\"> While possible, it is less frequent than PTHrP production as the cause of hypercalcemia in squamous cell lung cancer.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. All of the above:</span></strong><span style=\"font-size:12.0pt\"> Although all three mechanisms can contribute to hypercalcemia in SCC, PTHrP-mediated bone resorption is the most prevalent.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PTHrP-mediated bone resorption is the predominant mechanism of hypercalcemia in squamous cell lung cancer and certain other malignancies.</span></span></span></p>",
      "correct_choice_id": 79293,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19834,
      "choices": [
        {
          "id": 79297,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oral calcium supplements</span></span></span></p>"
        },
        {
          "id": 79298,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Intravenous bisphosphonates</span></span></span></p>"
        },
        {
          "id": 79299,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Thiazide diuretics</span></span></span></p>"
        },
        {
          "id": 79300,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calcitonin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 70-year-old man with advanced lung cancer presents with confusion, polyuria, and dehydration. Laboratory tests reveal a serum calcium level of 13.5 mg/dL. The most likely diagnosis is humoral hypercalcemia of malignancy. Which of the following is the most appropriate initial treatment?</span></span></p>",
      "unique_key": "Q3789940",
      "question_audio": null,
      "question_video": null,
      "map_id": 19745,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Intravenous bisphosphonates</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s clinical presentation and high serum calcium level suggest a diagnosis of hypercalcemia of malignancy. This condition is most commonly associated with certain types of cancer, including lung cancer, and is often mediated by the secretion of parathyroid hormone-related peptide (PTHrP) by tumor cells, leading to increased bone resorption and calcium release into the bloodstream. The initial treatment of choice for hypercalcemia of malignancy is aggressive hydration with intravenous fluids to restore intravascular volume and promote renal excretion of calcium, followed by the administration of intravenous bisphosphonates. Bisphosphonates such as pamidronate or zoledronic acid inhibit bone resorption and can help lower serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Oral calcium supplements</strong>: Would be contraindicated as the patient already has hypercalcemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Thiazide diuretics</strong>: Would be inappropriate as they tend to increase serum calcium levels by promoting renal reabsorption of calcium.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><span style=\"font-size:12pt\"><strong>D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Calcitonin</strong>: Can be used as an additional therapy for hypercalcemia, but it has a much weaker effect compared to bisphosphonates and is often used in conjunction with bisphosphonates for a quicker response.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The appropriate initial management of hypercalcemia of malignancy involves the use of intravenous bisphosphonates, after initial hydration with intravenous fluids. Bisphosphonates inhibit osteoclastic bone resorption and reduce serum calcium levels</span></span></p>",
      "correct_choice_id": 79298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "TreatmentBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19836,
      "choices": [
        {
          "id": 79305,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperparathyroidism </span></span></span></p>"
        },
        {
          "id": 79306,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sarcoidosis </span></span></span></p>"
        },
        {
          "id": 79307,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma </span></span></span></p>"
        },
        {
          "id": 79308,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Humoral hypercalcemia of malignancy</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 55-year-old woman complains of fatigue, constipation, increased thirst and urination, decreased appetite, and unintentional weight loss. Labs reveal hypercalcemia, normal creatinine, suppressed PTH, and elevated PTHrP. A chest X-ray identifies a right upper lung mass. What is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q3882817",
      "question_audio": null,
      "question_video": null,
      "map_id": 19789,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Humoral hypercalcemia of malignancy</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of hypercalcemia with suppressed PTH and elevated PTHrP, along with a lung mass, points strongly towards humoral hypercalcemia of malignancy (HHM). This occurs when a tumor secretes PTHrP, mimicking the action of PTH and causing increased bone resorption and calcium release.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Primary hyperparathyroidism:</span></strong><span style=\"font-size:12.0pt\"> This would cause hypercalcemia but with elevated PTH levels, not suppressed.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Sarcoidosis:</span></strong><span style=\"font-size:12.0pt\"> Sarcoidosis can cause hypercalcemia due to increased vitamin D production, but PTHrP would not be elevated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Multiple myeloma:</span></strong><span style=\"font-size:12.0pt\"> While myeloma can cause hypercalcemia through bone destruction, PTHrP is usually not elevated.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of hypercalcemia, suppressed PTH, and elevated PTHrP in the setting of a malignancy is indicative of humoral hypercalcemia of malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Question Id-19836 Unique Key-Q3882817</span></span></strong></p>",
      "correct_choice_id": 79308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19837,
      "choices": [
        {
          "id": 79309,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Central diabetes insipidus </span></span></span></p>"
        },
        {
          "id": 79310,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Nephrogenic diabetes insipidus </span></span></span></p>"
        },
        {
          "id": 79311,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syndrome of inappropriate antidiuretic hormone secretion (SIADH) </span></span></span></p>"
        },
        {
          "id": 79312,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperaldosteronism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of small cell lung cancer (SCLC) presents with confusion, lethargy, and muscle cramps. Laboratory findings reveal hyponatremia with a serum sodium level of 120 mEq/L, high urine sodium, and high urine osmolality. Which of the following is the MOST likely diagnosis?</span></span></p>",
      "unique_key": "Q1077488",
      "question_audio": null,
      "question_video": null,
      "map_id": 19790,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C.</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation with hyponatremia, high urine sodium, and high urine osmolality, in the context of SCLC, is consistent with SIADH. SCLC is a known cause of SIADH due to ectopic production of vasopressin (ADH). The other options do not fit the clinical and laboratory picture.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Central diabetes insipidus:</span></strong><span style=\"font-size:12.0pt\"> This condition is caused by deficient production of ADH, leading to excessive water loss and hypernatremia (high serum sodium), not hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Nephrogenic diabetes insipidus:</span></strong><span style=\"font-size:12.0pt\"> In this condition, the kidneys are unable to respond to ADH, also leading to excessive water loss and hypernatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Primary hyperaldosteronism:</span></strong><span style=\"font-size:12.0pt\"> This condition is characterized by excessive aldosterone production, leading to sodium retention, hypertension, and hypokalemia. It does not typically cause hyponatremia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">SIADH is characterized by hyponatremia with inappropriately concentrated urine due to excessive ADH secretion. SCLC is a common cause of SIADH.</span></span></p>",
      "correct_choice_id": 79311,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19838,
      "choices": [
        {
          "id": 79313,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ectopic ACTH production </span></span></span></p>"
        },
        {
          "id": 79314,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary adrenal adenoma </span></span></span></p>"
        },
        {
          "id": 79315,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pituitary ACTH-secreting adenoma (Cushing&#39;s disease) </span></span></span></p>"
        },
        {
          "id": 79316,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exogenous glucocorticoid use</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 55-year-old woman smoker with a recent diagnosis of small cell lung cancer (SCLC) presents with rapid weight gain, proximal muscle weakness, and easy bruising. She also reports experiencing mood swings and insomnia. On examination, she has central obesity, facial plethora, and purple striae on her abdomen. Her blood pressure is 150/90 mmHg. Further investigations reveal hypokalemia and hyperglycemia. Which of the following is the MOST likely underlying mechanism for her clinical presentation?</span></span></span></p>",
      "unique_key": "Q9220117",
      "question_audio": null,
      "question_video": null,
      "map_id": 19791,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Ectopic ACTH production </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of Cushingoid features (central obesity, facial plethora, purple striae, hypertension, hypokalemia, hyperglycemia) in a patient with SCLC strongly suggests ectopic ACTH production. SCLC is a common cause of ectopic Cushing&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Primary adrenal adenoma:</span></strong><span style=\"font-size:12.0pt\"> While an adrenal adenoma could cause Cushing&#39;s syndrome, it wouldn&#39;t explain the recent onset of symptoms in the context of SCLC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Pituitary ACTH-secreting adenoma (Cushing&#39;s disease):</span></strong><span style=\"font-size:12.0pt\"> Cushing&#39;s disease is less likely in this scenario, especially with a known SCLC diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Exogenous glucocorticoid use:</span></strong><span style=\"font-size:12.0pt\"> This is less likely given the absence of a history of glucocorticoid use and the presence of SCLC.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ectopic Cushing&#39;s syndrome is a paraneoplastic syndrome caused by the ectopic production of ACTH by non-pituitary tumors.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognizing the clinical features of Cushing&#39;s syndrome in patients with cancer is crucial for prompt diagnosis and management.</span></span></span></p>",
      "correct_choice_id": 79313,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19839,
      "choices": [
        {
          "id": 79317,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Serum cortisol </span></span></span></p>"
        },
        {
          "id": 79318,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">24-hour urinary 5-HIAA </span></span></span></p>"
        },
        {
          "id": 79319,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Serum calcitonin </span></span></span></p>"
        },
        {
          "id": 79320,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum gastrin</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 45-year-old woman presents with recurrent episodes of flushing, accompanied by diarrhea and abdominal cramping. She has also noticed a rash on her face and neck that worsens during these episodes. On physical examination, you note telangiectasias on her cheeks and a palpable liver mass. Which of the following diagnostic tests is MOST likely to be elevated in this patient?</span></span></p>",
      "unique_key": "Q9966236",
      "question_audio": null,
      "question_video": null,
      "map_id": 19792,
      "difficulty_level": "intermediate",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) 24-hour urinary 5-HIAA</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of flushing, diarrhea, skin changes, and a palpable liver mass raises strong suspicion for carcinoid syndrome. Carcinoid tumors secrete vasoactive substances, primarily serotonin, leading to these characteristic symptoms. 24-hour urinary 5-HIAA (a metabolite of serotonin) is the most sensitive and specific test for diagnosing carcinoid syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Serum cortisol:</span></strong><span style=\"font-size:12.0pt\"> Cortisol is elevated in Cushing&#39;s syndrome, which presents with different clinical features (central obesity, muscle weakness, hypertension).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum calcitonin:</span></strong><span style=\"font-size:12.0pt\"> Calcitonin is a marker for medullary thyroid carcinoma (MTC), which can also cause flushing but usually presents with a neck mass or thyroid nodules.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum gastrin:</span></strong><span style=\"font-size:12.0pt\"> Gastrin is elevated in gastrinomas (a type of neuroendocrine tumor), which primarily cause peptic ulcers and abdominal pain, not the classic carcinoid syndrome symptoms.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carcinoid syndrome is caused by the release of vasoactive substances, mainly serotonin, from carcinoid tumors.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">24-hour urinary 5-HIAA is the diagnostic test of choice for carcinoid syndrome.</span></span></li>\r\n</ul>",
      "correct_choice_id": 79318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "InvestigationBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 19840,
      "choices": [
        {
          "id": 79321,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Insulinoma </span></span></span></p>"
        },
        {
          "id": 79322,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Adrenal insufficiency </span></span></span></p>"
        },
        {
          "id": 79323,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ectopic production of IGF-2 by the tumor </span></span></span></p>"
        },
        {
          "id": 79324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Pituitary insufficiency</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man with a history of weight loss and fatigue presents with recurrent episodes of confusion, sweating, and tremors. These episodes typically occur in the morning or after prolonged fasting. His blood glucose level during one of these episodes is 40 mg/dL. Abdominal imaging reveals a large retroperitoneal mass. Which of the following is the MOST likely cause of this patient&#39;s hypoglycemia?</span></span></p>",
      "unique_key": "Q1912981",
      "question_audio": null,
      "question_video": null,
      "map_id": 19793,
      "difficulty_level": "difficult",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Ectopic production of IGF-2 by the tumor</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-islet cell hypoglycemia is a rare paraneoplastic syndrome associated with certain mesenchymal and hepatic tumors, as well as gastrointestinal stromal tumors (GISTs).</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation with hypoglycemia, weight loss, and a retroperitoneal mass suggests a paraneoplastic syndrome.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common mechanism of non-islet cell hypoglycemia is the ectopic production of IGF-2 (insulin-like growth factor 2) by the tumor. IGF-2 can have insulin-like effects, leading to decreased glucose production and increased glucose uptake by tissues.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Insulinoma:</span></strong><span style=\"font-size:12.0pt\"> Insulinomas are pancreatic neuroendocrine tumors that secrete insulin, leading to hypoglycemia. However, the presence of a retroperitoneal mass makes this less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Adrenal insufficiency:</span></strong><span style=\"font-size:12.0pt\"> Adrenal insufficiency can cause hypoglycemia, but it&#39;s usually associated with other symptoms like hypotension, fatigue, and hyperpigmentation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pituitary insufficiency:</span></strong><span style=\"font-size:12.0pt\"> Pituitary insufficiency can cause secondary adrenal insufficiency, which can lead to hypoglycemia. However, it&#39;s less likely in this patient with a retroperitoneal mass.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non-islet cell hypoglycemia is a rare but important paraneoplastic syndrome associated with certain tumors.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognizing this syndrome is crucial for proper management and treatment of the underlying malignancy.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 79323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53430,
      "choices": [
        {
          "id": 213201,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Primary hyperparathyroidism </span></span></span></p>"
        },
        {
          "id": 213202,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D deficiency </span></span></span></p>"
        },
        {
          "id": 213203,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mesenchymal tumor producing FGF23 </span></span></span></p>"
        },
        {
          "id": 213204,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple myeloma</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 50-year-old man presents with persistent bone pain and muscle weakness for several months. He has a history of recurrent fractures. Laboratory findings show hypophosphatemia, normal serum calcium, and decreased 1,25-dihydroxyvitamin D levels. Imaging studies reveal multiple bone lesions. Which of the following is the MOST likely underlying cause of his condition?</span></span></p>",
      "unique_key": "Q9219581",
      "question_audio": null,
      "question_video": null,
      "map_id": 25234,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>C) Mesenchymal tumor producing FGF23</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of bone pain, muscle weakness, recurrent fractures, hypophosphatemia, normal calcium, and decreased 1,25-dihydroxyvitamin D levels strongly suggests oncogenic osteomalacia. This rare paraneoplastic syndrome is caused by tumors that secrete fibroblast growth factor 23 (FGF23), leading to renal phosphate wasting and impaired vitamin D activation. The image lists hemangiopericytomas, fibromas, sarcomas, giant cell tumors, and osteoblastomas as potential culprits, along with prostate and lung cancers.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Primary hyperparathyroidism:</span></strong><span style=\"font-size:12.0pt\"> This would cause hypercalcemia, not hypophosphatemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Vitamin D deficiency:</span></strong><span style=\"font-size:12.0pt\"> This would also cause hypophosphatemia, but 1,25-dihydroxyvitamin D levels would be low or inappropriately normal, not decreased.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Multiple myeloma:</span></strong><span style=\"font-size:12.0pt\"> Myeloma can cause bone pain and fractures, but it typically presents with hypercalcemia and renal insufficiency.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oncogenic osteomalacia is a rare paraneoplastic syndrome caused by tumors that secrete FGF23.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Recognizing the characteristic clinical and laboratory findings is crucial for prompt diagnosis and treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identifying and removing the underlying tumor can lead to resolution of the osteomalacia.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 213203,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53431,
      "choices": [
        {
          "id": 213205,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Male breast cancer</span></span></span></p>"
        },
        {
          "id": 213206,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gynecomastia</span></span></span></p>"
        },
        {
          "id": 213207,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Male feminization</span></span></span></p>"
        },
        {
          "id": 213208,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Non cancerous breast lump</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 60-year-old man presents to his primary care physician with complaints of breast tenderness and enlargement over the past 3 months. He has also noticed a significant decrease in his libido and erectile function during this time. On physical examination, you note bilateral gynecomastia without palpable masses and testicular atrophy. Laboratory findings reveal a normal testosterone level, elevated estradiol level, and a slightly elevated hCG level. A chest CT scan demonstrates a mass in the right lung&#39;s lower lobe, with no evidence of metastasis. Which of the following is the most likely diagnosis?</span></span></p>",
      "unique_key": "Q6327904",
      "question_audio": null,
      "question_video": null,
      "map_id": 25235,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Male feminization</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The presentation of breast tenderness and enlargement (gynecomastia), decreased libido, and erectile dysfunction in the context of normal testosterone levels, elevated estradiol levels, and slightly elevated human chorionic gonadotropin (hCG) levels, along with the finding of a lung mass, suggests male feminization syndrome. This condition, also known as paraneoplastic hyperestrogenism, occurs when certain tumors, particularly lung tumors like non-small cell lung cancer, produce hormones or hormone-like substances (in this case, hCG, which can stimulate estrogen production) leading to feminization effects in males. The lung mass identified on the chest CT scan, combined with the hormonal findings, supports this diagnosis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Male breast cancer: </strong>Usually presents as a unilateral, hard, and sometimes painful mass located beneath the nipple, without necessarily being associated with elevated estradiol levels or symptoms of feminization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">B. </span></strong><span style=\"font-size:12.0pt\"><strong>Gynecomastia:&nbsp;</strong>Refers to the benign enlargement of breast tissue in males and can be a component of male feminization syndrome, but by itself, it does not explain the full clinical picture, including the lung mass and hormonal imbalances.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option&nbsp;</span></strong><strong><span style=\"font-size:12.0pt\">D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Non-cancerous breast lumps:</strong> Can cause breast enlargement, but they do not typically lead to hormonal changes like elevated estradiol or the systemic symptoms of feminization.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Male feminization syndrome, or paraneoplastic hyperestrogenism, can occur when tumors (commonly lung tumors) produce hormones or hormone-like substances leading to elevated estrogen levels, resulting in feminization effects such as gynecomastia, decreased libido, and erectile dysfunction. The diagnosis is supported by the presence of a lung mass, normal testosterone, elevated estradiol, and slightly elevated hCG levels. </span></span></p>",
      "correct_choice_id": 213207,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53432,
      "choices": [
        {
          "id": 213209,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Dermatomyositis</span></span></span></p>"
        },
        {
          "id": 213210,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Paraneoplastic pemphigus</span></span></span></p>"
        },
        {
          "id": 213211,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Pyoderma gangrenosum</span></span></span></p>"
        },
        {
          "id": 213212,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sweet syndrome</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old male with acute myeloid leukemia presents with stomatitis as shown in the image. What is the most likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-162506.jpg\" style=\"height:202px; width:300px\" /></span></span></span></p>",
      "unique_key": "Q5783810",
      "question_audio": null,
      "question_video": null,
      "map_id": 25236,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Paraneoplastic pemphigus</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation of severe stomatitis with erosive and ulcerative lesions in the context of acute myeloid leukemia is most suggestive of paraneoplastic pemphigus (PNP). Paraneoplastic pemphigus is an autoimmune blistering disorder that can be associated with underlying malignancies, most commonly hematologic cancers such as leukemia and lymphoma. It is characterized by painful mucosal erosions and polymorphous skin lesions. The severe stomatitis seen in the image is consistent with the mucosal involvement typically seen in PNP.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Dermatomyositis: </strong>Generally presents with a heliotrope rash (purple discoloration around the eyes) and Gottron&#39;s papules, not typically with the severe oral involvement shown.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Pyoderma gangrenosum:</strong>&nbsp;Is a neutrophilic dermatosis that usually presents as rapidly progressing painful skin ulcers, primarily on the legs, not in the oral cavity.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Sweet syndrome:</strong>&nbsp;or acute febrile neutrophilic dermatosis, presents with painful erythematous plaques on the skin, typically without the severe mucosal involvement depicted.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Paraneoplastic pemphigus is associated with underlying malignancies and presents with painful mucosal erosions and various skin lesions. It is important to recognize the oral manifestations which can be severe and impact a patient&#39;s ability to eat and maintain oral hygiene.</span></span></span></p>",
      "correct_choice_id": 213210,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53433,
      "choices": [
        {
          "id": 213213,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chronic lymphocytic leukemia</span></span></span></p>"
        },
        {
          "id": 213214,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myelodysplastic syndrome</span></span></span></p>"
        },
        {
          "id": 213215,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hodgkin&#39;s lymphoma</span></span></span></p>"
        },
        {
          "id": 213216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polycythemia vera</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 58-year-old male patient presents with fever, arthralgia, and painful erythematous plaques on her upper extremities as shown in the image. Laboratory tests reveal leukocytosis with neutrophilia and anemia. A bone marrow biopsy is performed, suspecting an underlying hematological disorder. Which of the following conditions is most likely associated with this patient&#39;s presentation?</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-163404.jpg\" style=\"height:266px; width:300px\" /></span></span></p>",
      "unique_key": "Q5464784",
      "question_audio": null,
      "question_video": null,
      "map_id": 25237,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Myelodysplastic syndrome</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s presentation of fever, arthralgia, and painful erythematous plaques, along with leukocytosis with neutrophilia and anemia, is suggestive of Sweet&#39;s syndrome, also known as acute febrile neutrophilic dermatosis. This condition is often associated with hematological malignancies and disorders. Sweet&#39;s syndrome is characterized by the abrupt onset of painful, erythematous, and edematous plaques, typically accompanied by systemic symptoms such as fever and arthralgias. It is frequently associated with hematologic disorders, and among them, myelodysplastic syndrome is one of the most common associations. This syndrome can sometimes precede, occur concurrently with, or follow the diagnosis of the associated hematological malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A.</span></strong><span style=\"font-size:12.0pt\"> <strong>Chronic lymphocytic leukemia (CLL):</strong> May be associated with various skin manifestations, but Sweet&#39;s syndrome is more classically associated with myeloid disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong><span style=\"font-size:12.0pt\"> <strong>Hodgkin&#39;s lymphoma:</strong> Is not commonly associated with Sweet&#39;s syndrome. Hodgkin&#39;s lymphoma typically presents with lymphadenopathy and sometimes with B symptoms (fever, weight loss, night sweats), but not typically with the cutaneous manifestations seen in Sweet&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D.</span></strong><span style=\"font-size:12.0pt\"> <strong>Polycythemia vera:&nbsp;</strong>Could present with a plethoric face and splenomegaly and is a myeloproliferative disorder, but it is not the hematologic disorder most typically associated with Sweet&#39;s syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sweet&#39;s syndrome, characterized by painful erythematous plaques, fever, and arthralgias, is often associated with hematological disorders, particularly myelodysplastic syndrome.</span></span></span></p>",
      "correct_choice_id": 213214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53434,
      "choices": [
        {
          "id": 213217,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Addison&#39;s disease </span></span></p>"
        },
        {
          "id": 213218,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin resistance </span></span></p>"
        },
        {
          "id": 213219,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Gastric adenocarcinoma </span></span></p>"
        },
        {
          "id": 213220,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hypothyroidism</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 48-year-old male, with a known case of GERD presents with a 6-month history of weight loss, decreased appetite along with darkening and thickening of the skin on his neck and axillae. The areas are asymptomatic but have been progressively worsening. He has no other significant past medical history. On examination, you note hyperpigmented, velvety plaques in the affected areas along with the small nodule near the umblicus. Given the patient&#39;s presentation, which of the following is the MOST likely underlying condition?</span></span></p>",
      "unique_key": "Q6233642",
      "question_audio": null,
      "question_video": null,
      "map_id": 25238,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Gastric adenocarcinoma</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient&#39;s rapid-onset acanthosis nigricans, combined with weight loss, decreased appetite, and the presence of a Sister Mary Joseph nodule (a sign of metastatic cancer, often from an abdominal malignancy), points strongly toward an underlying malignancy. Gastric adenocarcinoma is the most frequent malignancy associated with acanthosis nigricans in adults, especially when it has an aggressive presentation like this.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Addison&#39;s disease:</span></strong><span style=\"font-size:12.0pt\"> While Addison&#39;s disease can cause hyperpigmentation, it is typically more diffuse and doesn&#39;t have the velvety texture characteristic of acanthosis nigricans. Additionally, Addison&#39;s disease would present with other symptoms like hypotension, fatigue, and electrolyte imbalances.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Insulin resistance:</span></strong><span style=\"font-size:12.0pt\"> While insulin resistance can cause acanthosis nigricans, it&#39;s usually seen in younger individuals with obesity and metabolic syndrome. The rapid progression, associated symptoms, and the presence of a Sister Mary Joseph nodule in this case point more towards malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Hypothyroidism can cause skin changes like dryness and coarseness, but it doesn&#39;t typically cause the velvety hyperpigmentation seen in acanthosis nigricans.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rapidly progressive acanthosis nigricans in an adult, especially with associated symptoms like weight loss, decreased appetite, and the presence of a Sister Mary Joseph nodule, should prompt immediate investigation for an underlying malignancy.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Gastric adenocarcinoma is the most common malignancy associated with acanthosis nigricans in adults, and the presence of a Sister Mary Joseph nodule further supports this possibility.</span></span></span></p>",
      "correct_choice_id": 213219,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "DiagnosisBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 53435,
      "choices": [
        {
          "id": 213221,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic lupus erythematosus (SLE) </span></span></span></p>"
        },
        {
          "id": 213222,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dermatomyositis </span></span></span></p>"
        },
        {
          "id": 213223,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Scleroderma </span></span></span></p>"
        },
        {
          "id": 213224,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Polymyositis</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old woman presents with progressive muscle weakness and peculiar rashes present on her knuckles and eyes as shown below. She also reports difficulty swallowing and has noticed a scaly rash over her shoulders and upper back. Which of the following is the MOST likely diagnosis?</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/07/screenshot-2024-08-07-163958.jpg\" style=\"height:226px; width:500px\" /></span></span></span></p>",
      "unique_key": "Q2584110",
      "question_audio": null,
      "question_video": null,
      "map_id": 25239,
      "difficulty_level": "beginner",
      "subjects_id": [
        11
      ],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Dermatomyositis</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B.</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The combination of the characteristic skin findings (heliotrope rash, Gottron&#39;s papules, shawl sign) and muscle weakness is highly suggestive of dermatomyositis. The difficulty swallowing (dysphagia) further supports the diagnosis, as it can be a manifestation of muscle involvement in the esophagus.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Explanation: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Systemic lupus erythematosus (SLE):</span></strong><span style=\"font-size:12.0pt\"> While SLE can cause a malar rash and muscle weakness, it doesn&#39;t typically present with the specific skin findings seen in dermatomyositis (heliotrope rash, Gottron&#39;s papules, shawl sign).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Scleroderma:</span></strong><span style=\"font-size:12.0pt\"> Scleroderma primarily affects the skin and internal organs, causing thickening and tightening of the skin. It doesn&#39;t typically present with the muscle weakness or characteristic rash seen in dermatomyositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Polymyositis:</span></strong><span style=\"font-size:12.0pt\"> Polymyositis presents with muscle weakness but lacks the characteristic skin manifestations of dermatomyositis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dermatomyositis is an inflammatory myopathy characterized by muscle weakness and distinctive skin manifestations. It is also associated with an increased risk of malignancy, particularly ovarian cancer.</span></span></span></p>",
      "correct_choice_id": 213222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [
        "ClinicalVignette",
        "ImageBased"
      ],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}